COVID-19 , COVID-19 Related Compounds


  • Catalog Number : C5115
  • Number :
  • Size:
    Qty :
  • Price : 0 詢價
  • Stock : Request
  • print


Mechanism of action: EIDD-2801 is hydrolyzed in vivo to N4-hydroxycytidine, which is phosphorylated in tissue to the active 5’-triphosphate form, and incorporated into the genome of new virions, resulting in the accumulation of inactivating mutations, known as viral error catastrophe.A remdesivir resistant mutant mouse hepatitis virus has also been shown to have increased sensitivity to N4-hydroxycytidine.Indication: EIDD-1931 and its prodrug EIDD-2801 is being studied for its activity against a number of viral infections including influenza, MERS-CoV, and SARS-CoV-2.Absorption: EIDD-2801 is orally bioavailable in non-human primates.Metabolism:EIDD-2801 is hydrolyzed to N4-hydroxycytidine, which distributes into tissues.<2> Once inside cells, N4-hydroxycytidine is phosphorylated to the 5'-triphosphate form.

General Information

Cas No. 2349386-89-4
Purity >99%
Molecular Weight 329.31
Formula C13H19N3O7
Solubility DMSO : 100 mg/mL
Storage instruction 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Alias EIDD2801,EIDD 2801


gotop link
客製化服務 產品 聯絡我們